ALEXANDER KAY to Rifampin
This is a "connection" page, showing publications ALEXANDER KAY has written about Rifampin.
Connection Strength
2.011
-
Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children. Cochrane Database Syst Rev. 2025 10 23; 10:CD013359.
Score: 0.860
-
Targeted next-generation sequencing implementation in Eswatini identifies rifampicin and bedaquiline resistance undetected by routine diagnostic testing. Nat Commun. 2026 Jun 11; 17(1).
Score: 0.225
-
Xpert MTB/RIF Ultra assay for pulmonary tuberculosis and rifampicin resistance in adults and adolescents. Cochrane Database Syst Rev. 2025 07 29; 7:CD009593.
Score: 0.212
-
Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children. Cochrane Database Syst Rev. 2022 09 06; 9:CD013359.
Score: 0.173
-
Vikela Ekhaya: A Novel, Community-based, Tuberculosis Contact Management Program in a High Burden Setting. Clin Infect Dis. 2022 05 03; 74(9):1631-1638.
Score: 0.169
-
It Ain't Over Till It's Over: The Triple Threat of COVID-19, TB, and HIV. Am J Trop Med Hyg. 2020 10; 103(4):1348-1349.
Score: 0.151
-
Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children. Cochrane Database Syst Rev. 2020 08 27; 8:CD013359.
Score: 0.150
-
Renal and miliary tuberculosis in an internationally adopted infant. Pediatr Infect Dis J. 2009 Aug; 28(8):751-3.
Score: 0.070